Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klapper

Showing results (991-1000 of 1,153) with videos related to

Pageof 116
Sort By:
Blood|January 22, 2013
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphomaHeike Horn, Marita Ziepert, Claudia Becher, et al.
Blood|May 4, 2011
Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker ConsortiumGilles Salles, Daphne de Jong, Wanling Xie, et al.
Transfusion|June 1, 2019
Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine CommitteeClaudia S Cohn, Elizabeth S Allen, Melissa M Cushing, et al.
Frontiers in Oncology|October 11, 2024
Case report: Tenosynovial giant cell tumorAnke Fähnrich, Zhala Gasimova, Yamil Maluje, et al.
The Lancet Regional Health. Europe|July 25, 2024
Corrigendum to "Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)" [The Lancet Regional Health - Europe 40 (2024) 100892]Marianne Leruez-Ville, Christos Chatzakis, Daniele Lilleri, et al.
Hemasphere|December 8, 2022
First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA TrialFriederike Braulke, Florian Zettl, Marita Ziepert, et al.
Leukemia|January 5, 2023
Molecular profiling of EBV associated diffuse large B-cell lymphomaFabian Frontzek, Annette M Staiger, Ramona Wullenkord, et al.
Leukemia|June 27, 2008
Pathway activation patterns in diffuse large B-cell lymphomasS Bentink, S Wessendorf, C Schwaenen, et al.
Leukemia & Lymphoma|October 2, 2012
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Hanneke C Kluin-Nelemans, Sílvia Beà, et al.
Haematologica|May 9, 2020
Whole-slide image analysis of the tumor microenvironment identifies low B-cell content as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPPRon Daniel Jachimowicz, Luise Pieper, Sarah Reinke, et al.
Pageof 116

Showing results (991-1000 of 1,153) with videos related to

Sort By:
Pageof 116
Blood|January 22, 2013
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphomaHeike Horn, Marita Ziepert, Claudia Becher, et al.
Blood|May 4, 2011
Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker ConsortiumGilles Salles, Daphne de Jong, Wanling Xie, et al.
Transfusion|June 1, 2019
Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine CommitteeClaudia S Cohn, Elizabeth S Allen, Melissa M Cushing, et al.
Frontiers in Oncology|October 11, 2024
Case report: Tenosynovial giant cell tumorAnke Fähnrich, Zhala Gasimova, Yamil Maluje, et al.
The Lancet Regional Health. Europe|July 25, 2024
Corrigendum to "Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)" [The Lancet Regional Health - Europe 40 (2024) 100892]Marianne Leruez-Ville, Christos Chatzakis, Daniele Lilleri, et al.
Hemasphere|December 8, 2022
First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA TrialFriederike Braulke, Florian Zettl, Marita Ziepert, et al.
Leukemia|January 5, 2023
Molecular profiling of EBV associated diffuse large B-cell lymphomaFabian Frontzek, Annette M Staiger, Ramona Wullenkord, et al.
Leukemia|June 27, 2008
Pathway activation patterns in diffuse large B-cell lymphomasS Bentink, S Wessendorf, C Schwaenen, et al.
Leukemia & Lymphoma|October 2, 2012
Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Hanneke C Kluin-Nelemans, Sílvia Beà, et al.
Haematologica|May 9, 2020
Whole-slide image analysis of the tumor microenvironment identifies low B-cell content as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPPRon Daniel Jachimowicz, Luise Pieper, Sarah Reinke, et al.
Pageof 116